Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma
Johannes F. Fahrmann, Ichidai Tanaka, Ehsan Irajizad, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2543-2543
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The KEAP1-NRF2 pathway: Targets for therapy and role in cancer
Simone Adinolfi, Tommi Patinen, Ashik Jawahar Deen, et al.
Redox Biology (2023) Vol. 63, pp. 102726-102726
Open Access | Times Cited: 101
Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks
Ke Xu, Jie Ma, Sean R. R. Hall, et al.
Theranostics (2023) Vol. 13, Iss. 2, pp. 704-723
Open Access | Times Cited: 37
Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis
Ricardo A. León-Letelier, Ali H. Abdel Sater, Yihui Chen, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 834-834
Open Access | Times Cited: 14
NRF2 signaling pathway in chemo/radio/immuno-therapy resistance of lung cancer: Looking beyond the tip of the iceberg
Sri Vidya Ramisetti, Tapas Patra, Vinayak Munirathnam, et al.
Archivos de Bronconeumología (2024) Vol. 60, pp. S59-S66
Closed Access | Times Cited: 5
Construction of a lung adenocarcinoma prognostic model based on KEAP1/NRF2/HO‑1 mutation‑mediated upregulated genes and bioinformatic analysis
Wei Zhu, Zhang Ye, Lingyun Yang, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access
Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis
John D. Hayes, Sharadha Dayalan Naidu, Albena T. Dinkova‐Kostova
Trends in Biochemical Sciences (2025)
Open Access
The Kynurenine Pathway and Indole Pathway in Tryptophan Metabolism Influence Tumor Progression
Zhan‐Hui Lu, Chengcheng Zhang, Jia Zhang, et al.
Cancer Medicine (2025) Vol. 14, Iss. 6
Open Access
Nrf2 in TIME: The Emerging Role of Nuclear Factor Erythroid 2-Related Factor 2 in the Tumor Immune Microenvironment
Jialin Feng, Oliver J. Read, Albena T. Dinkova‐Kostova
Molecules and Cells (2023) Vol. 46, Iss. 3, pp. 142-152
Open Access | Times Cited: 11
The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer
Ricardo A. León-Letelier, Rongzhang Dou, Jody V. Vykoukal, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
KYNU Expression Promotes Cisplatin Resistance in Esophageal Cancer
Lu Yu, Xianyang Zhao, Mingliang Yuan, et al.
Journal of Cancer (2024) Vol. 15, Iss. 9, pp. 2475-2485
Open Access | Times Cited: 2
Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders
Adrian Mor, Anna Tankiewicz‐Kwedlo, Marianna Ciwun, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1259-1259
Open Access | Times Cited: 2
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
Nerea Otegui, Maeva Houry, Imanol Arozarena, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3076-3076
Open Access | Times Cited: 6
Kynureninase Promotes Immunosuppression and Predicts Survival in Glioma Patients: In Silico Data Analyses of the Chinese Glioma Genome Atlas (CGGA) and of the Cancer Genome Atlas (TCGA)
Gonzalo Pérez de la Cruz, Verónica Pérez de la Cruz, Javier Navarro Cossio, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 369-369
Open Access | Times Cited: 4
Targeted inhibition of NRF2 reduces the invasive and metastatic ability of HIP1 depleted lung cancer cells
Peeyush Prasad, Jonita Chongtham, S. C. Tripathi, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 733, pp. 150676-150676
Closed Access | Times Cited: 1
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells
Davide Capoferri, Paola Chiodelli, Marzia Corli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10555-10555
Open Access | Times Cited: 3
Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies
Ichidai Tanaka, Junji Koyama, Hideyuki Itoigawa, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Nrf2 depletion in the context of loss-of-function Keap1 leads to mitolysosome accumulation
Sharadha Dayalan Naidu, Plamena R. Angelova, Elena V. Knatko, et al.
Free Radical Biology and Medicine (2023) Vol. 208, pp. 478-493
Open Access | Times Cited: 3
A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response
Ehsan Irajizad, Johannes F. Fahrmann, James P. Long, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8933-8933
Open Access | Times Cited: 5
Bioinformatic Analysis of Kynurenine Pathway Enzymes and Their Relationship with Glioma Hallmarks
Gustavo Ignacio Vázquez Cervantes, Javier Ángel Navarro Cossio, Gonzalo Pérez de la Cruz, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1054-1054
Open Access | Times Cited: 3
Neutrophil in the suppressed immune microenvironment: Critical prognostic factor for lung adenocarcinoma patients with KEAP1 mutation
Zhongzhao Wang, Haojue Wang, Mingjia Liu, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
NRF2 signaling and amino acid metabolism in cancer
Suji Ham, Bo-Hyun Choi, Mi-Kyoung Kwak
Free Radical Research (2024) Vol. 58, Iss. 10, pp. 648-661
Closed Access
Efficacy of glutathione inhibitor eprenetapopt against the vulnerability of glutathione metabolism in SMARCA4-, SMARCB1- and PBRM1-deficient cancer cells
Mariko Sasaki, Hideaki Ogiwara
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Identification of Cuproptosis-Related Subtypes in Lung Cancer, Characterization of Tumor Microenvironment Infiltration, and Establishment of a Prognostic Model
Jin Cui, Ying Xiong, Yuting Liu, et al.
BioMed Research International (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 1
EGFR inhibition in lung adenocarcinoma upregulates cell surface expression of the placental antigen ALPP and enhances efficacy of ALPP-ADC therapy
Yihui Chen, Monica Hong, Hanwen Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma
Zhengsong Jiang, Xiang Wang, Jinghan Huang, et al.
Open Medicine (2023) Vol. 18, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top